title: Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
abstract: It has been suggested that the expression of certain HLA class II antigens stemming from three distinct loci (DR, DP, and DQ) is important not only in the regulation of the immune response but also on the response of hemopoietic precursors to factors inhibiting myelopoiesis. Changes in the expression of DR antigens may be involved in the pathogenesis of altered cell proliferation in chronic myeloid leukemia, since they result in decreased sensitivity of the colony forming units, granulocyte-macrophage to prostaglandin E and acidic isoferritins. In studies using monoclonal antibodies against monomorphic DR or DQ determinants, in a complement-dependent cytotoxic assay, it was found that nearly all normal and chronic myeloid leukemia bone marrow colony forming units, granulocyte-macrophage express DR antigens. The dose response curve was similar for both normal and leukemic precursors. Leukemic peripheral blood precursors were more sensitive than were normal peripheral blood precursors. Normal colony forming units, granulocyte-macrophage did not express DQ antigens, whereas these were expressed in varying quantities by leukemic cells. This study shows that, in the patients we studied, leukemic cells express DR antigens in amounts comparable to normal. In addition, varying amounts of DQ antigens may be observed on leukemic but not on normal progenitors, perhaps as a consequence of an increase in the number of antigens also expressed by normal cells, though in an amount below the detection threshold of cytotoxicity techniques.
authors.forename: M
authors.initials: M
authors.lastname: Aglietta
authors.forename: W
authors.initials: W
authors.lastname: Piacibello
authors.forename: A
authors.initials: A
authors.lastname: Stacchini
authors.forename: L
authors.initials: L
authors.lastname: Dezza
authors.forename: F
authors.initials: F
authors.lastname: Sanavio
authors.forename: F
authors.initials: F
authors.lastname: Malavasi
authors.forename: V
authors.initials: V
authors.lastname: Infelise
authors.forename: L
authors.initials: L
authors.lastname: Resegotti
authors.forename: F
authors.initials: F
authors.lastname: Gavosto
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006098:Granulocytes / Q000276:immunology*; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D006412:Hematopoietic Stem Cells / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D006801:Humans; D007951:Leukemia, Myeloid / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009000:Monocytes / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D003165:Complement System Proteins